Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 17.36
+0.42 (2.48%)
Sep 12, 2025, 3:45 PM HKT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 37.98 billion as of September 12, 2025. Its market cap has increased by 42.29% in one year.
Market Cap
37.98B
Enterprise Value
34.96B
Revenue
6.50B
Ranking
n/a
PE Ratio
1.55
Stock Price
17.36
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 37.98B, an increase of 1,698.16%. That is a compound annual growth rate of 34.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 37.02B | 75.46% |
| Dec 31, 2024 | 21.10B | -49.96% |
| Dec 29, 2023 | 42.16B | -19.78% |
| Dec 30, 2022 | 52.56B | -27.50% |
| Dec 31, 2021 | 72.50B | 229.03% |
| Dec 31, 2020 | 22.03B | -33.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 287.68B |
| JD Health International | 220.26B |
| Hansoh Pharmaceutical Group Company | 213.09B |
| Innovent Biologics | 166.31B |
| Sino Biopharmaceutical | 150.95B |
| WuXi Biologics | 146.30B |
| Akeso | 124.81B |
| CSPC Pharmaceutical Group | 115.70B |